Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action

Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion

(2013) Yuxian He   CURRENT PHARMACEUTICAL DESIGN

Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide

(2012) Sarah Harman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential Effect of Cholesterol and Its Biosynthetic Precursors on Membrane Dipole Potential

(2012) Sourav Haldar et al.   BIOPHYSICAL JOURNAL

Microbicides: still a long road to success

(2012) Christophe Vanpouille et al.   TRENDS IN MICROBIOLOGY

The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide

(2010) Pedro M. Matos et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Quantitative assessment of peptide–lipid interactions.

(2010) Pedro M. Matos et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes

(2010) Pedro M. Matos et al.   PLoS One

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life

(2009) D. Xie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Peptides in the treatment of AIDS

(2009) Fred Naider et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions

(2009) Zoltan Beck et al.   PLoS One

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

(2009) P. Ingallinella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility

(2008) Weijing He et al.   Cell Host & Microbe

Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection

(2008) Sharon S. Lieberman-Blum et al.   CLINICAL THERAPEUTICS

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV

(2008) Erik De Clercq   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor

(2008) Cheryl A. Stoddart et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides

(2008) Henri G. Franquelim et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Process Development of TRI-999, a Fatty-Acid-Modified HIV Fusion Inhibitory Peptide

(2007) Huyi Zhang et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT